Article Per Year (5 Year)
p-Index From 2020 - 2025
1.325
P-Index
This Author published in this journals
All Journal SAINS MEDIKA : JURNAL KEDOKTERAN DAN KESEHATAN Pharmacon SELAPARANG: Jurnal Pengabdian Masyarakat Berkemajuan Pharmed: Journal of Pharmaceutical Science and Medical Research JFM (Jurnal Farmasi Malahayati) Jurnal Farmasi dan Sains Indonesia (JFSI) Archives Pharmacia Media Farmasi Indonesia Indonesian Journal of Community Empowerment (IJCE)
Willi Wahyu Timur
Program Studi Farmasi Fakultas Kedokteran Universitas Islam Sultan Agung Semarang
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Chemistry Computer Science & IT Control & Systems Engineering Economics, Econometrics & Finance Education Engineering Environmental Science Health Professions Immunology & microbiology Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Neuroscience Nursing Public Health Social Sciences Other

Published : 9 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : JFM (Jurnal Farmasi Malahayati)

 1 
PERBANDINGAN EFEKTIFITAS OBAT ANTIHIPERTENSI ORAL ANTARA CANDESARTAN DAN VALSARTAN PADA PASIEN RAWAT JALAN DI RUMAH SAKIT ISLAM SULTAN AGUNG SEMARANG Timur, Willi Wahyu; Mufadillah, Isna Naili; Mardiyanti, Devi
JFM (Jurnal Farmasi Malahayati) Vol 8, No 1 (2025)
Publisher : Jurnal Farmasi Malahayati (JFM)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33024/jfm.v8i1.18616

Abstract

Hypertension is a non-communicable disease that is responsible for 72% of deaths worldwide. One of the main health problems is the high prevalence of hypertension, along with the increasing number of new cases. The 2023 SKI results show a high prevalence of hypertension of 30.8% based on the results of checking blood pressure levels. The aim of this research is to find out how effective the two ARB antihypertensive drugs, namely Candesartan and Valsartan, are used at the Sultan Agung Islamic Hospital, Semarang. The population of this study were outpatient hypertensive patients who took the drugs Candesartan and Valsartan at the Sultan Agung Islamic Hospital, Semarang in the 2023 period. This study is an observational analysis conducted with a retrospective design. The purposive sampling technique produced 100 samples. Based on the results of the Man Whitney statistical test, there is no significant difference between the use of Candesartan and Valsartan in reducing blood pressure in outpatients at the Sultan Agung Islamic Hospital, Semarang. The conclusion of this research is that the p value is > 0.05.Key words: Hypertension, Effectiveness, Candesartan, Valsartan 
Co-Authors Abdur Rosyid Amajida, Neva Linsya Chilmia Nurul Fatiha Dewi, Peggy Anastia Dewi, Rissa Maharani Fita Rahmawati Hanum, Dayyana Rizkya Kurniawati , Indah Lukman Hakim Mardiyanti, Devi Mufadillah, Isna Naili nafirin, Athikan Naniek Widyaningrum Oktavia, Shelomita Risti Riyanta Aribawa Sabiti, Farroh Bintang Tri Diana Puspita Rini Tri Murti Andayani